SavedAdd your journal

Journals / Tıp Araştırmaları Dergisi / 2014 / Cilt: 12 - Sayı: 1

Central Corneal Thickness Evaluation after CornealCollagen Cross-Linking for Keratoconus

Keratokonusta Korneal Kollajen Çapraz BağlamaSonrası Merkezi Kornea Kalınlığının Değerlendirilmesi

Nodirbek KOCHKAROV
Banu ACAR
Alev KAHYA
Pages
15–19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But thinning in CCT was not statistically significant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate central corneal thickness (CCT) after corneal collagen cross-linking (CXL) with riboflavin using ultraviolet-A light for keratoconus.
📊
Key Findings & Data:Materials and Methods: Thirty seven eyes of 37 patients with progressive keratoconus were included in this retrospective study.
💡
Conclusion & Impact:But thinning in CCT was not statistically significant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

To evaluate central corneal thickness (CCT) after corneal collagen cross-linking (CXL) with riboflavin using ultraviolet-A light for keratoconus. Materials and Methods: Thirty seven eyes of 37 patients with progressive keratoconus were included in this retrospective study. During the follow up period CCT were recorded at the first, third and sixth months. Results: The mean preoperative CCT was 468.43zk32.76 um (412-524) (n=37); Postoperative 1. month 461.47:h34.37 um (410-520) (n=35); 3.month 468.16:k33.95 um (413-530) (n=30); 6. month 464.53:t37.91 um (420- 516) (n=23). There was no statistically significant change in CCT (p>0.05). Conclusion: After CXL the cornea thins and then recovers toward baseline thickness. But thinning in CCT was not statistically significant.

Özet

Keratokonusta ultraviole-A ve riboflavin kullanarak yapılan korneal kollajen çapraz bağlama (KKÇB) sonrası merkezi kornea kalınlığının (MKK) değerlendirilmesi. Materyal ve Metod: Bu retrospektif çalışmada ilerleyici keratokonuslu 37 hastanın 37 gözü değerlendirildi. Hastaların ameliyat öncesi ve sonrası 1., 3., 6. aylardaki takiplerde elde edilen MKK değerleri kaydedildi. Bulgular: Hastaların ortalama MKK ameliyat öncesi 468,43:l:32,76 um (412-524) (n=37); ameliyat sonrası 1. ay 461,47:|:34,37 um (410-520) (n=35); 3. ay 468,16:|:33,95 um (413-530) (n=30); 6. ay 464,53:I:37,91 um (420-516) (n=23) idi. MKK değerlerinde istatistiksel olarak anlamlı değişiklik saptanmadı (p>0,05). Sonuç: KKÇB sonrasi MKK'da incelme meydana gelmiştir ve daha sonra ameliyat öncesi değerlere ulaşmiştir. Ama MKK'daki incelme istatistiksel olarak anlamlı bulunmamıştır.

🔖

Cite This Article

KOCHKAROV, N., ACAR, B., KAHYA, A. (2014). Central Corneal Thickness Evaluation after CornealCollagen Cross-Linking for Keratoconus. Tıp Araştırmaları Dergisi, Cilt: 12 - Sayı: 1, 15–19. https://ajindex.com/articles/361814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Espandar L, Meyer J. Keratoconus: Overview and Update on treatment. Middle East Afr Ophtalmol. 2010; 17:15-20.
  2. Edwards M, McGhee C.N, Dean S. The genetics of keratoconus. Clin Experiment Ophthalmol. 2001; 29:345—51. Rabinowitz YS: Keratoconus. Surv Ophthalmol. 1998; 42:297—319. Smith VA, Hoh HB, Littleton M, Easty DL. Over—expression of gelatinase activity in keratoconus. Eye (Lond) 1995; 9:429—33. Smith VA, Easty DL. Matrix metalloproteinase 2: involvement in keratoconus. Eur Ophthalmol. 2000; 10:215—26. Parkin BT, Smith VA, Easty DL. The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures. Eur Ophthalmol. 2000; 10:276—85. Spoerl E, Huhle M, Seiler T. Induction of crosslinks in corneal tissue. Exp Eye Res. 1998; 66:97—103. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavinultraviolet-A treatment in the rabbit. Cataract Refract Surg. 2003; 29:1786—1790. Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE. Biomechanical evidence of the distribution of cross-links in corneas treated With riboflavin and ultraviolet light. Cataract Refract Surg. 2006; 32:279-283.
  3. Wollensak G, Spoerl E, Wilsch M, Seiler T. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea. 2004; 23:43-49.
  4. Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006; 25:1057— 1059. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA- riboflavin cross-linking of the cornea. Cornea. 2007; 26:385-389.
  5. Spoerl E, Seiler T. Techniques for stiffening the cornea. Refract Surg. 1999; 15:711—713. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced crosslinking. Cataract Refract Surg. 2003;29:1780- 1785. Wollensak G, Iomdina E, Dittert D, Herbst H. Wound healing in the rabbit cornea after corneal collagen cross-linking with riboflavin and UVA. Cornea. 2007;26:600-5.
  6. Wollensak G, Aurich H, Wirbelauer C. Potential use of riboflavin/UVA crosslinking in bullous keratopathy. Ophtalmic Res. 2009; 41:114—117. Ehlers N, Hjortdal J, Nielsen K. Riboflavin—UVA treatment in the management of edema and nonhealing ulcers of the cornea. Refract Surg. 2009; 25:803—806. Greenstein A, ShahVP, Fry KL. Corneal thickness changes after corneal collogen crosslinking for keratoconus and korneal ectasia: One-year results. Cataract Refract Surg. 2011; 37:691-700.
  7. Grewal DS, Br